<p>ABLE Financial Group LLC 在第三季度购买了 CVS Health Corporation (NYSE:CVS - 免费报告) 的新股份，根据其最近向证券交易委员会提交的 13F 文件。该基金购买了 41,227 股该药房运营商的股票，价值约为 3,108,000 美元。</p>
<ul>
<li>CVS Health 收益增长，股息保持强劲</li>
</ul>
<p>其他机构投资者和对冲基金也对该公司的持股进行了调整。Avion Wealth 在第二季度将其在 CVS Health 的持股增加了 99.0%。Avion Wealth 目前拥有 380 股该药房运营商的股票，价值 26,000 美元，在此期间又购买了 189 股。Harbor Asset Planning Inc. 在第二季度获得了 CVS Health 的新股份，价值约为 30,000 美元。Bell Investment Advisors Inc 在第一季度将其在 CVS Health 的持股增加了 119.8%。Bell Investment Advisors Inc 目前拥有 455 股该药房运营商的股票，价值 31,000 美元，在上个季度又购买了 248 股。Front Row Advisors LLC 在第二季度将其在 CVS Health 的持股增加了 436.5%。Front Row Advisors LLC 目前拥有 456 股该药房运营商的股票，价值 31,000 美元，在上个季度又购买了 371 股。最后，Roxbury Financial LLC 在第二季度将其在 CVS Health 的持股增加了 78.3%。Roxbury Financial LLC 目前拥有 460 股该药房运营商的股票，价值 32,000 美元，在此期间又购买了 202 股。当前 80.66% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师评级变动</h2>
<p>多家券商最近对 CVS 发布了报告。高盛集团将 CVS Health 的目标价从 93.00 美元上调至 95.00 美元，并在 12 月 10 日的报告中给予该股票 &#34;买入&#34; 评级。Truist Financial 在 12 月 10 日的研究报告中设定了 CVS Health 的目标价为 100.00 美元。Wolfe Research 在 12 月 8 日的研究报告中将 CVS Health 的目标价从 85.00 美元上调至 100.00 美元，并给予公司 &#34;跑赢大盘&#34; 评级。Jefferies Financial Group 在 10 月 30 日的报告中将 CVS Health 的目标价从 92.00 美元上调至 98.00 美元。最后，Zacks Research 在 9 月 8 日的研究报告中将 CVS Health 的评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。两位投资分析师对该股票给予了强力买入评级，二十位给予了买入评级，四位给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 &#34;适度买入&#34;，共识目标价为 94.67 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
<p><strong>查看我们最新的 CVS 股票分析</strong></p>
<h2>CVS Health 股票表现</h2>
<p>CVS 的股票在周五开盘价为 77.70 美元。CVS Health Corporation 的 12 个月低点为 43.56 美元，12 个月高点为 85.15 美元。该股票的市值为 986.3 亿美元，市盈率为 204.47，市盈增长比率为 0.77，贝塔系数为 0.48。该公司的 50 日移动平均线为 79.09 美元，200 日移动平均线为 72.43 美元。该公司的债务与股本比率为 0.83，流动比率为 0.83，速动比率为 0.63。</p>
<ul>
<li>现在是购买诺和诺德股票的好时机吗？</li>
</ul>
<p>CVS Health (NYSE:CVS - 获取免费报告) 最近在 10 月 29 日发布了其财报。该药房运营商报告本季度每股收益为 1.60 美元，超过分析师一致预期的 1.36 美元，超出 0.24 美元。该公司本季度的收入为 1,028.7 亿美元，而分析师预期为 988.5 亿美元。CVS Health 的净利润率为 0.12%，股本回报率为 11.45%。该公司本季度的收入同比增长 7.8%。去年同期，该公司每股收益为 1.09 美元。CVS Health 已将其 2025 财年的指导目标设定为 6.550-6.650 每股收益。股票研究分析师预计 CVS Health Corporation 本财年将发布 5.89 每股收益。</p>
<h2>CVS Health 公司简介</h2>
<p>(免费报告)</p>
<p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗保健解决方案。公司总部位于罗德岛州的伍恩索克特，追溯其根源至 1960 年代初期，已发展成为一个综合的处方药、非处方产品、临床服务和健康保险产品的提供者。其运营模式结合了零售药房和店内诊所以及更广泛的药房和健康计划能力。</p>
<p>主要业务活动包括 CVS 药房零售运营、MinuteClinic 诊所和提供扩展临床服务的 HealthHUB 位置。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票超过 CVS Health</li>
<li>精通纪律：克服交易中的情绪挑战</li>
<li>这三家银行在年末反弹，但这种趋势会持续吗？</li>
<li>如何知道一只股票是否支付股息以及何时支付</li>
<li>三只飙升的股票刚刚获得标准普尔 500 的最终批准</li>
<li>如何计算投资回报率 (ROI)</li>
<li>该 ETF 在美联储降息后获得了重大顺风</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

<p>ABLE Financial Group LLC 在第三季度收购了 41,227 股 CVS Health Corporation 的股票，价值约为 3,108,000 美元。此交易已在他们最新的 13F 文件中向 SEC 报告。CVS Health 的股票主要由机构投资者持有，拥有比例为 80.66%。分析师对该股票给予了 “适度买入” 的共识评级，目标价为 94.67 美元。CVS Health 报告了强劲的收益，年同比收入增长 7.8%，并将其 2025 财年的每股收益指导定在 6.550-6.650</p>

<p>ABLE Financial Group LLC bought a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the third quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commission. The fund bought 41,227 shares of the pharmacy operator's stock, valued at approximately $3,108,000.</p>
<div class="lb-trans"><p>ABLE Financial Group LLC 在第三季度购买了 CVS Health Corporation (NYSE:CVS - 免费报告) 的新股份，根据其最近向证券交易委员会提交的 13F 文件。该基金购买了 41,227 股该药房运营商的股票，价值约为 3,108,000 美元。</p>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 收益增长，股息保持强劲</li>
</ul>
</div><p>Other institutional investors and hedge funds have also made changes to their positions in the company. Avion Wealth increased its position in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator's stock worth $26,000 after buying an additional 189 shares during the period. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health in the 2nd quarter worth about $30,000. Bell Investment Advisors Inc lifted its position in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock valued at $31,000 after purchasing an additional 248 shares during the last quarter. Front Row Advisors LLC grew its position in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator's stock worth $31,000 after purchasing an additional 371 shares during the last quarter. Finally, Roxbury Financial LLC increased its stake in shares of CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 202 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他机构投资者和对冲基金也对该公司的持股进行了调整。Avion Wealth 在第二季度将其在 CVS Health 的持股增加了 99.0%。Avion Wealth 目前拥有 380 股该药房运营商的股票，价值 26,000 美元，在此期间又购买了 189 股。Harbor Asset Planning Inc. 在第二季度获得了 CVS Health 的新股份，价值约为 30,000 美元。Bell Investment Advisors Inc 在第一季度将其在 CVS Health 的持股增加了 119.8%。Bell Investment Advisors Inc 目前拥有 455 股该药房运营商的股票，价值 31,000 美元，在上个季度又购买了 248 股。Front Row Advisors LLC 在第二季度将其在 CVS Health 的持股增加了 436.5%。Front Row Advisors LLC 目前拥有 456 股该药房运营商的股票，价值 31,000 美元，在上个季度又购买了 371 股。最后，Roxbury Financial LLC 在第二季度将其在 CVS Health 的持股增加了 78.3%。Roxbury Financial LLC 目前拥有 460 股该药房运营商的股票，价值 32,000 美元，在此期间又购买了 202 股。当前 80.66% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of brokerages recently issued reports on CVS. The Goldman Sachs Group increased their price objective on CVS Health from $93.00 to $95.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, December 10th. Truist Financial set a $100.00 price target on CVS Health in a research note on Wednesday, December 10th. Wolfe Research lifted their price objective on shares of CVS Health from $85.00 to $100.00 and gave the company an &#34;outperform&#34; rating in a research note on Monday, December 8th. Jefferies Financial Group upped their price objective on shares of CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Finally, Zacks Research cut shares of CVS Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Monday, September 8th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $94.67.</p>
<div class="lb-trans"><p>多家券商最近对 CVS 发布了报告。高盛集团将 CVS Health 的目标价从 93.00 美元上调至 95.00 美元，并在 12 月 10 日的报告中给予该股票 &#34;买入&#34; 评级。Truist Financial 在 12 月 10 日的研究报告中设定了 CVS Health 的目标价为 100.00 美元。Wolfe Research 在 12 月 8 日的研究报告中将 CVS Health 的目标价从 85.00 美元上调至 100.00 美元，并给予公司 &#34;跑赢大盘&#34; 评级。Jefferies Financial Group 在 10 月 30 日的报告中将 CVS Health 的目标价从 92.00 美元上调至 98.00 美元。最后，Zacks Research 在 9 月 8 日的研究报告中将 CVS Health 的评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。两位投资分析师对该股票给予了强力买入评级，二十位给予了买入评级，四位给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 &#34;适度买入&#34;，共识目标价为 94.67 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Analysis on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 CVS 股票分析</strong></p>
</div><h2>CVS Health Stock Performance</h2>
<div class="lb-trans"><h2>CVS Health 股票表现</h2>
</div><p>Shares of CVS opened at $77.70 on Friday. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The stock has a market capitalization of $98.63 billion, a P/E ratio of 204.47, a P/E/G ratio of 0.77 and a beta of 0.48. The firm's 50 day moving average is $79.09 and its 200-day moving average is $72.43. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.</p>
<div class="lb-trans"><p>CVS 的股票在周五开盘价为 77.70 美元。CVS Health Corporation 的 12 个月低点为 43.56 美元，12 个月高点为 85.15 美元。该股票的市值为 986.3 亿美元，市盈率为 204.47，市盈增长比率为 0.77，贝塔系数为 0.48。该公司的 50 日移动平均线为 79.09 美元，200 日移动平均线为 72.43 美元。该公司的债务与股本比率为 0.83，流动比率为 0.83，速动比率为 0.63。</p>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>现在是购买诺和诺德股票的好时机吗？</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts' expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>CVS Health (NYSE:CVS - 获取免费报告) 最近在 10 月 29 日发布了其财报。该药房运营商报告本季度每股收益为 1.60 美元，超过分析师一致预期的 1.36 美元，超出 0.24 美元。该公司本季度的收入为 1,028.7 亿美元，而分析师预期为 988.5 亿美元。CVS Health 的净利润率为 0.12%，股本回报率为 11.45%。该公司本季度的收入同比增长 7.8%。去年同期，该公司每股收益为 1.09 美元。CVS Health 已将其 2025 财年的指导目标设定为 6.550-6.650 每股收益。股票研究分析师预计 CVS Health Corporation 本财年将发布 5.89 每股收益。</p>
</div><h2>CVS Health Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.</p>
<div class="lb-trans"><p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗保健解决方案。公司总部位于罗德岛州的伍恩索克特，追溯其根源至 1960 年代初期，已发展成为一个综合的处方药、非处方产品、临床服务和健康保险产品的提供者。其运营模式结合了零售药房和店内诊所以及更广泛的药房和健康计划能力。</p>
</div><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p>
<div class="lb-trans"><p>主要业务活动包括 CVS 药房零售运营、MinuteClinic 诊所和提供扩展临床服务的 HealthHUB 位置。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Mastering Discipline: Overcoming Emotional Challenges In Trading</li>
<li>These 3 Banks Are Rallying Into Year-End, But Will It Continue?</li>
<li>How to Know if a Stock Pays Dividends and When They Are Paid Out</li>
<li>3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&amp;P 500</li>
<li>How to Calculate Return on Investment (ROI)</li>
<li>This ETF Caught a Major Tailwind After the Fed’s Rate Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 CVS Health</li>
<li>精通纪律：克服交易中的情绪挑战</li>
<li>这三家银行在年末反弹，但这种趋势会持续吗？</li>
<li>如何知道一只股票是否支付股息以及何时支付</li>
<li>三只飙升的股票刚刚获得标准普尔 500 的最终批准</li>
<li>如何计算投资回报率 (ROI)</li>
<li>该 ETF 在美联储降息后获得了重大顺风</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

ABLE Financial Group LLC 购买了 41,227 股西维斯健康公司（CVS Health Corporation）的股票